ArticleCureus2026
Closed-Loop Extracorporeal Vascular Cleaning by Staged Chemical Dissolution.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A closed-loop extracorporeal system for the removal of atherosclerotic plaque from accessible vascular segments by targeted chemical dissolution in a blood-free environment is proposed. The target segment is isolated by balloon occlusion, drained of blood, and connected to an external bypass that maintains distal perfusion. With the treatment zone converted to a sealed saline chamber, concentrated chemical agents, each targeting a specific plaque component, dissolve the atheroma in situ: ethylenediaminetetraacetic acid (EDTA) for calcified deposits, surfactants for the lipid-rich necrotic core, and collagenase for the fibrous cap. The agents are cycled iteratively to penetrate layered plaque, and dissolved material is flushed out under alternating unidirectional flow, with real-time effluent chemistry providing both treatment endpoint and quantitative plaque composition without imaging. The access geometry uses n+1 balloon catheters to isolate arbitrary vessel topologies, from straight segments to bifurcations and higher-order branch points. An iterative protocol interleaves gentle cleaning sessions with pharmacological lipid and calcium mobilization, progressively draining plaque burden from inaccessible microvascular sites toward accessible ones. Six testable predictions are specified for validation in a porcine atherosclerosis model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.